Sinovac Biotech Ltd (SVA) — Net Asset Momentum
Sinovac Biotech Ltd (SVA) recorded a net asset momentum of -37.8% as of December 2025, with net assets of $6.40 Billion USD. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See shareholders equity of Sinovac Biotech Ltd for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
Sinovac Biotech Ltd Net Asset Momentum (1998–2025)
This chart tracks Sinovac Biotech Ltd's year-over-year net asset growth across 27 annual reporting periods from 1998 to 2025. The most recent momentum reading is -37.8%, with net assets of $6.40 Billion USD as of December 2025. For live market cap and overall valuation, see SVA stock market capitalisation.
Annual Net Asset History for Sinovac Biotech Ltd (1998–2025)
The table below shows the complete annual net asset history for Sinovac Biotech Ltd from 1998 to 2025, covering 27 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check tangible equity quality of Sinovac Biotech Ltd to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (USD) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | $6.40 Billion | $8.64 Billion | $2.23 Billion | ▼ -37.8% |
| 2024 | $10.29 Billion | $12.34 Billion | $2.04 Billion | ▼ -14.4% |
| 2023 | $12.02 Billion | $13.66 Billion | $1.64 Billion | ▼ -5.4% |
| 2022 | $12.71 Billion | $14.11 Billion | $1.40 Billion | ▼ -8.4% |
| 2021 | $13.88 Billion | $16.75 Billion | $2.87 Billion | ▲ +1138.8% |
| 2020 | $1.12 Billion | $1.90 Billion | $781.20 Million | ▲ +218.0% |
| 2019 | $352.19 Million | $452.30 Million | $100.10 Million | ▲ +20.6% |
| 2018 | $291.93 Million | $369.78 Million | $77.85 Million | ▲ +125.1% |
| 2017 | $129.67 Million | $211.35 Million | $81.69 Million | ▲ +0.0% |
| 2016 | $129.67 Million | $211.35 Million | $81.69 Million | ▼ -5.0% |
| 2015 | $136.50 Million | $202.93 Million | $66.42 Million | ▼ -3.7% |
| 2014 | $141.73 Million | $238.53 Million | $96.80 Million | ▼ -1.3% |
| 2013 | $143.64 Million | $240.69 Million | $97.05 Million | ▲ +11.0% |
| 2012 | $129.44 Million | $208.76 Million | $79.33 Million | ▼ -10.9% |
| 2011 | $145.30 Million | $215.91 Million | $70.61 Million | ▼ -1.7% |
| 2010 | $147.76 Million | $214.36 Million | $66.60 Million | ▲ +74.9% |
| 2009 | $84.47 Million | $145.48 Million | $61.01 Million | ▲ +57.5% |
| 2008 | $53.64 Million | $77.44 Million | $23.80 Million | ▲ +63.0% |
| 2007 | $32.90 Million | $57.45 Million | $24.55 Million | ▲ +54.4% |
| 2006 | $21.31 Million | $37.01 Million | $15.70 Million | ▲ +29.1% |
| 2005 | $16.51 Million | $23.37 Million | $6.86 Million | ▲ +6.1% |
| 2004 | $15.56 Million | $22.42 Million | $6.86 Million | ▲ +42.9% |
| 2003 | $10.89 Million | $14.90 Million | $4.01 Million | ▲ +10848.5% |
| 2002 | $99.44K | $236.25K | $136.81K | ▲ +114.6% |
| 2001 | $-682.96K | $269.19K | $952.15K | ▲ +0.0% |
| 2000 | $-682.96K | $269.19K | $952.15K | ▼ -2454.5% |
| 1998 | $29.01K | $33.51K | $4.50K | — |